Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Author:

Reale Maria Lucia,De Luca Emmanuele,Lombardi Pasquale,Marandino Laura,Zichi Clizia,Pignataro Daniele,Ghisoni Eleonora,Di Stefano Rosario F.,Mariniello Annapaola,Trevisi ElenaORCID,Leone Gianmarco,Muratori LeonardoORCID,La Salvia AnnaORCID,Sonetto Cristina,Bironzo PaoloORCID,Aglietta Massimo,Novello Silvia,Scagliotti Giorgio V.,Perrone FrancescoORCID,Di Maio MassimoORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. An update on predictive biomarkers for treatment selection in non-small cell lung cancer;Ahmadzada;J. Clin. Med.,2018

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int. J. Cancer,2019

3. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims;U.S. Food and Drug Administration,2009

4. Reflection paper on the use of patient reported outcome measure in oncology studies. June 17;European Medicines Agency,2014

5. American society of clinical oncology statement: a conceptual framework to assess the value of cancer treatment options;Schnipper;J. Clin. Oncol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3